Skip to main content

Odyssey Health, Inc.

corporate_fare Company Profile

Odyssey Health, Inc.

ODYY·OTC·Industrial Applications And Services·CIK 0001626644

Odyssey Health, Inc. is a Nevada corporation formed in March 2014 that aims to create or acquire distinct assets, intellectual property, and technologies, with an emphasis on acquisition targets that have superior clinical utility and serve an unmet medical need. Its business model is to develop or acquire medical-related products, engage third parties to help develop such products, complete clinical trials, and manufacture products according to U.S. Food and Drug Administration regulations. The company has two technologies it plans to develop: the CardioMap heart monitoring and screening device and the Save-A-Life choking rescue device. It intends to acquire other technologies and assets and plans to be a trans-disciplinary product development company involved in the discovery, development and commercialization of products and technologies that may be applied over various medical markets. Odyssey Health plans to license, improve and/or develop its products and identify and select distribution channels. It intends to establish agreements with distributors to get products to market quickly as well as to undertake and engage in its own direct marketing efforts, and it will determine the most effective method of distribution for each unique product in its portfolio. Its principal executive offices are located at 2300 West Sahara Avenue, Suite 800 - #4012, Las Vegas, Nevada, 89102. The registration statement effectuating its initial public offering became effective in July 2015, and its shares of common stock are listed on the OTCID Marketplace, where there is currently very little public market for its common stock.

Odyssey Health, Inc. (OTC:ODYY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 8 items for ODYY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 9/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for ODYY spans 10-K, 10-Q, 8-K.

Recent high-impact activity:

  • Odyssey Health 10-K: Going Concern, $12.1M Working Capital Hole, 1.06B Dilutive Shares
  • Odyssey Health Swings to Q3 Net Income of $766K, Reports $0.01 EPS
  • Odyssey Health Reports Worsening Financials, Going Concern Warning, and Key Agreement Termination
  • Odyssey Health Extends $1.05M Promissory Note Maturity to September 2026
  • Odyssey Health Loses Exclusive Global Distribution Rights for BreastCheck Product

Financial Snapshot

Fiscal year ended July 31, 2026
Net Income
-$5.73M
Diluted EPS
-$0.05
Op. Cash Flow
-$1.05M
Operating Income
-$912.99K
Cash & Equivalents
$122.36K
Debt / Equity
0.00×
Shares Outstanding
105.97M sh
Source: 10-K · filed 2026-10-28 · accession 0001683168-26-008124

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 64,027 shares in ODYY as of the October 30, 2026 settlement, a 116.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 39.8% of ODYY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)64,027 shares as of October 30, 2026
Change vs prior period▲ 116.6%
Days to cover1.00 at avg daily volume of 358,279
Daily short volume (FINRA facilities)39.8% of 24,100 shares on November 20, 2026
5-day average short volume36.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with O →
$0.0065
52-week range · as of 2026-10-28 $0.0041 – $0.125
Market cap
$716.42K
Volume
24.1K (0.3× avg)
3-mo avg 94.2K
Live data · 2026-11-22 04:49 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ODYY - Latest Insights

ODYY
Oct 28, 2026, 8:06 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.00752
Real-time Price: $0.0065 info
Change: -$0.00102 (-14%) info
Market Cap: $716.421K info
ODYY
Jun 12, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.0068
Real-time Price: $0.0065 info
Change: -$0.0003 (-4%) info
Market Cap: $716.421K info
ODYY
Jun 12, 2026, 5:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0068
Real-time Price: $0.0065 info
Change: -$0.0003 (-4%) info
Market Cap: $716.421K info
ODYY
May 22, 2026, 7:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0195
Real-time Price: $0.0065 info
Change: -$0.013 (-67%) info
Market Cap: $716.421K info
ODYY
May 11, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0502
Real-time Price: $0.0065 info
Change: -$0.0437 (-87%) info
Market Cap: $716.421K info
ODYY
Apr 24, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0544
Real-time Price: $0.0065 info
Change: -$0.0479 (-88%) info
Market Cap: $716.421K info
ODYY
Mar 11, 2026, 6:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.052
Real-time Price: $0.0065 info
Change: -$0.0455 (-88%) info
Market Cap: $716.421K info
ODYY
Feb 03, 2026, 5:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0648
Real-time Price: $0.0065 info
Change: -$0.0583 (-90%) info
Market Cap: $716.421K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets